Neuronal Ceroid Lipofuscinosis in a Mixed-Breed Dog with a Splice Site Variant in CLN6
Genes · 2024
DOI: 10.3390/genes15060661 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2024. Verfasst von Tendai Mhlanga-Mutangadura und 3 weiteren Autor:innen. Beteiligte Einrichtung: Canine Genetics Laboratory, Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA. Hauptthemen laut MEDLINE: Neuronal Ceroid-Lipofuscinoses, Dog Diseases. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, U.S. National Institutes of Health.
Abstract (Originalsprache)
A 23-month-old neutered male dog of unknown ancestry presented with a history of progressive neurological signs that included anxiety, cognitive impairment, tremors, seizure activity, ataxia, and pronounced visual impairment. The clinical signs were accompanied by global brain atrophy. Due to progression in the severity of disease signs, the dog was euthanized at 26 months of age. An examination of the tissues collected at necropsy revealed dramatic intracellular accumulations of autofluorescent inclusions in the brain, retina, and cardiac muscle. The inclusions were immunopositive for subunit c of mitochondrial ATP synthase, and their ultrastructural appearances were similar to those of lysosomal storage bodies that accumulate in some neuronal ceroid lipofuscinosis (NCL) diseases. The dog also exhibited widespread neuroinflammation. Based on these findings, the dog was deemed likely to have suffered from a form of NCL. A whole genome sequence analysis of the proband’s DNA revealed a homozygous C to T substitution that altered the intron 3–exon 4 splice site of CLN6. Other mutations in CLN6 cause NCL diseases in humans and animals, including dogs. The CLN6 protein was undetectable with immunolabeling in the tissues of the proband. Based on the clinical history, fluorescence and electron-microscopy, immunohistochemistry, and molecular genetic findings, the disorder in this dog was classified as an NCL resulting from the absence of the CLN6 protein. Screening the dog’s genome for a panel of breed-specific polymorphisms indicated that its ancestry included numerous breeds, with no single breed predominating. This suggests that the CLN6 disease variant is likely to be present in other mixed-breed dogs and at least some ancestral breeds, although it is likely to be rare since other cases have not been reported to date.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Canine Genetics Laboratory, Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
- MedVet Chicago, Chicago, IL 60618, USA.
- Neurodegenerative Diseases Research Laboratory, Department of Ophthalmology, School of Medicine, University of Missouri, Columbia, MO 65212, USA.
ORCID-Profile: Garrett Bullock, Martin L Katz
Förderung
- NEI NIH HHS
- NIH HHS
- U.S. National Institutes of Health
- American Kennel Club Canine Health Foundation
- Orthopedic Foundation for Animals
- National Science Foundation
- the computing resources of the University of Missouri Bioinformatics and Analytics Core Facility
Zitieren
APA
Mhlanga-Mutangadura, T., Bullock, G., Cerda-Gonzalez, S., & Katz, M. L. (2024). Neuronal Ceroid Lipofuscinosis in a Mixed-Breed Dog with a Splice Site Variant in CLN6. Genes. https://doi.org/10.3390/genes15060661
Vancouver
Mhlanga-Mutangadura T, Bullock G, Cerda-Gonzalez S, Katz ML. Neuronal Ceroid Lipofuscinosis in a Mixed-Breed Dog with a Splice Site Variant in CLN6. Genes. 2024. doi:10.3390/genes15060661
BibTeX
@article{MhlangaMutangadura2024,
author = {Mhlanga-Mutangadura, Tendai and Bullock, Garrett and Cerda-Gonzalez, Sofia and Katz, Martin L},
title = {Neuronal Ceroid Lipofuscinosis in a Mixed-Breed Dog with a Splice Site Variant in CLN6},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15060661}
}
EUVIMED